Role of TNF-α/TNFR1 in intense acute swimming-induced delayed onset muscle soreness in mice

Physiology and Behavior

Volumn 128, Issue , 2014, Pages 277-287

  Borghi, Sergio M ^a   Zarpelon, Ana C ^a   Pinho Ribeiro, Felipe A ^a   Cardoso, Renato D R ^a   Martins Pinge, Marli C ^a   Tatakihara, Roberto I ^a   Cunha, Thiago M ^b   Ferreira, Sergio H ^b   Cunha, Fernando Q ^b   Casagrande, Rubia ^a   Verri, Waldiceu A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DOMS; Hyperalgesia; Muscle pain; Oxidative stress; Swimming; TNF

Indexed keywords

ETANERCEPT; GLUCOSE; GLUTATHIONE; HYDROCORTISONE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; WATER; GLUCOSE BLOOD LEVEL; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; TNFR-FC FUSION PROTEIN; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED ONSET MUSCLE SORENESS; ENZYME ACTIVITY; EXERCISE; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; HYDROCORTISONE BLOOD LEVEL; HYPERALGESIA; INTENSE ACUTE SWIMMING; MALE; MOUSE; MUSCLE MECHANICAL HYPERALGESIA; MYALGIA; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; SPINAL CORD; SWIMMING; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; LEUKOCYTE; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCORTISONE; HYPERALGESIA; IMMUNOGLOBULIN G; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYALGIA; PEROXIDASE; PHYSICAL EXERTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SPINAL CORD; SWIMMING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900366578     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.01.023     Document Type: Article

References (75)

1. Batista M.L., Lopes R.D., Seelaender M.C.L., Lopes A.C. Anti-inflammatory effect of physical training in heart failure: role of TNF-α and IL-10. Arq Bras Cardiol 2009, 93(6):643-651.
2. Kuphal K.E., Fibuch E.E., Taylor B.K. Extended swimming exercise reduces inflammatory and peripheral neuropathic pain in rodents. J Pain 2007, 8(12):989-997.
3. Mazzardo-Martins L., Martins D.F., Marcon R., Dos Santos U.D., Speckhann B., Gadotti V.M., et al. High-intensity extended swimming exercise reduces pain-related behavior in mice: involvement of endogenous opioids and the serotonergic system. J Pain 2010, 11(12):1384-1393.
4. Sharma N.K., Ryals J.M., Gajewski B.J., Wright D.E. Aerobic exercise alters analgesia and neurotrophin-3 synthesis in an animal model of chronic widespread pain. Phys Ther 2010, 90(5):714-725.
5. Alvarez P., Levine J.D., Green P.G. Eccentric exercise induces chronic alterations in musculoskeletal nociception in the rat. Eur J Neurosci 2010, 32(5):819-825.
6. Quintero L., Moreno M., Avila C., Arcaya J., Maixner W., Suarez-Roca H. Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol Biochem Behav 2000, 67(3):449-458.
7. Quintero L., Cuesta M.C., Silva J.A., Arcaya J.L., Pinerua-Suhaibar L., Maixner W., et al. Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord. Brain Res 2003, 965(1-2):259-268.
8. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107(3):660-664.
9. Schäfers M., Sorkin L.S., Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003, 104(3):579-588.
10. Verri W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., Ferreira S.H. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol Ther 2006, 112(1):116-138.
11. Cleto L.S., Oleto A.F., Sousa L.P., Barreto T.O., Cruz J.S., Penaforte C.L., et al. Plasma cytokine response, lipid peroxidation and NF-kB activation in skeletal muscle following maximum progressive swimming. Braz J Med Biol Res 2011, 44(6):546-552.
12. Figueras M., Busquets S., Carbó N., Almendro V., Argilés J.M., López-Soriano F.J. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue. Int J Oncol 2005, 27(3):855-860.
13. Liburt N.R., Adams A.A., Betancourt A., Horohov D.W., McKeever K.H. Exercise-induced increases in inflammatory cytokines in muscle and blood of horses. Equine Vet J Suppl 2010, 38:280-288.
14. Pedersen B.K., Ostrowski K., Rohde T., Bruunsgaard H. The cytokine response to strenuous exercise. Can J Physiol Pharmacol 1998, 76(5):505-511.
15. Ming W.J., Bersani L., Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987, 138(5):1469-1474.
16. Atkinson Y.H., Marasco W.A., Lopez A.F., Vadas M.A. Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest 1988, 81(3):759-765.
17. Verri W.A., Souto F.O., Vieira S.M., Almeida S.C., Fukada S.Y., Xu D., et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010, 69(9):1697-1703.
18. Kilpatrick L.E., Sun S., Li H., Vary T.C., Korchak H.M. Regulation of TNF-induced oxygen radical production in human neutrophils: role of delta-PKC. J Leukoc Biol 2010, 87(1):153-164.
19. Powers S.K., Jackson M.J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008, 88(4):1243-1276.
20. Valério D.A., Georgetti S.R., Magro D.A., Casagrande R., Cunha T.M., Vicentini F.T., et al. Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production. J Nat Prod 2009, 72(11):1975-1979.
21. Martins-Pinge M.C., Becker L.K., Garcia M.R.L., Zoccal D.B., Neto R.V., Basso L.S., et al. Attenuated pressor responses to amino acids in the rostral ventrolateral medulla after swimming training in conscious rats. Auton Neurosci 2005, 112(1-2):21-28.
22. Cunha T.M., Verri W.A., Vivancos G.G., Moreira I.F., Reis S., Parada C.A., et al. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 2004, 37(3):401-407.
23. Guerrero A.T., Werri W.A., Cunha T.M., Silva T.A., Rocha F.A., Ferreira S.H., et al. Hypernociception elicited by tibio-tarsal joint flexion in mice: a novel experimental arthritis model for pharmacological screening. Pharmacol Biochem Behav 2006, 84(2):244-251.
24. Casagrande R., Georgetti S.R., Verri W.A., Dorta D.J., dos Santos A.C., Fonseca M.J. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B 2006, 84(1):21-27.
25. Verri W.A., Cunha T.M., Ferreira S.H., Wei X., Leung B.P., Fraser A., et al. IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 2007, 37(12):3373-3380.
26. Borghi S.M., Carvalho T.T., Staurengo-Ferrari L., Hohmann M.S., Pinge-Filho P., Casagrande R., et al. Vitexin inhibits inflammatory pain in mice by targeting TRPV1, oxidative stress, and cytokines. J Nat Prod 2013, 76(6):1141-1149.
27. Zarpelon A.C., Cunha T.M., Alves-Filho J.C., Pinto L.G., Ferreira S.H., McInnes I.B., et al. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. Br J Pharmacol 2013, 169(1):90-101.
28. Barnes J.N., Nualnim N., Sugawara J., Sommerlad S.M., Renzi C.P., Tanaka H. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients. Am J Hypertens 2011, 24(11):1194-1200.
29. Busch A.J., Webber S.C., Brachaniec M., Bidonde J., Bello-Haas V.D., Danyliw A.D., et al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep 2011, 15(5):358-367.
30. Scarvell J., Elkins M.R. Aerobic exercise is beneficial for people with rheumatoid arthritis. Br J Sports Med 2011, 45(12):1008-1009.
31. Myers V.H., McVay M.A., Brashear M.M., Johannsen N.M., Swift D.L., Kramer K., et al. Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial. Diabetes Care 2013, 36(7):1884-1890.
32. Vivancos G.G., Verri W.A., Cunha T.M., Schivo I.R., Parada C.A., Cunha F.Q., et al. An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 2004, 37(3):391-399.
33. Takahashi K., Taguchi T., Itoh K., Okada K., Kawakita K., Mizumura K. Influence of surface anesthesia on the pressure pain threshold measured with different-sized probes. Somatosens Mot Res 2005, 22(4):299-305.
34. Linden D.R., Jia Y.P., Seybold V.S. Spinal neurokin3 receptors facilitate the nociceptive flexor reflex via a pathway involving nitric oxide. Pain 1999, 80(1-2):301-308.
35. Ge H.Y., Serrao M., Andersen O.K., Graven-Nielsen T., Arendt-Nielsen L. Increased H-reflex response induced by intramuscular electrical stimulation of latent myofascial trigger points. Acupunct Med 2009, 27(4):150-154.
36. Courtney C.A., Witte P.O., Chmell S.J., Hornby T.G. Heightened flexor withdrawal response in individuals with knee osteoarthritis is modulated by joint compression and joint mobilization. J Pain 2010, 11(2):179-185.
37. Cunha T.M., Verri W.A., Fukada S.Y., Guerrero A.T., Santodomingo-Garzón T., Poole S., et al. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur J Pharmacol 2007, 573(1-3):221-229.
38. Cunha T.M., Verri W.A., Valério D.A., Guerrero A.T., Nogueira L.G., Vieira S.M., et al. Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice. Eur J Pain 2008, 12(8):1059-1068.
39. Guerrero A.T., Cunha T.M., Verri W.A., Gazzinelli R.T., Teixeira M.M., Cunha F.Q., et al. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-α, IL-1β and CXCL1/KC. Eur J Pharmacol 2012, 674(1):51-57.
40. Sommer C., Schmidt C., George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998, 151(1):138-1342.
41. Sommer C., Schäfers M., Marziniak M., Toyka K.V. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001, 6(2):67-72.
42. George A., Buehl A., Sommer C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol 2005, 192(1):163-166.
43. Uçeyler N., Schäfers M., Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res 2009, 196(1):67-78.
44. Meotti F.C., Campos R., da Silva K.A., Paszcuk A.F., Costa R., Calixto J.B. Inflammatory muscle pain is dependent on the activation of kinin B(1) and B(2) receptors and intracellular kinase pathways. Br J Pharmacol 2012, 166(3):1127-1139.
45. Shah J.P., Danoff J.V., Desai M.J., Parikh S., Nakamura L.Y., Phillips T.M., et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 2008, 89(1):16-23.
46. Rice T.L., Chantler I., Loram L.C. Neutralisation of muscle tumour necrosis factor alpha does not attenuate exercise-induced muscle pain but does improve muscle strength in healthy male volunteers. Br J Sports Med 2008, 42(9):758-762.
47. Murase S., Terazawa E., Queme F., Ota H., Matsuda T., Hirate K., et al. Bradykinin and nerve growth factor play pivotal roles in muscular mechanical hyperalgesia after exercise (delayed-onset muscle soreness). J Neurosci 2010, 30(10):3752-3761.
48. Braun J., McHugh N., Singh A., Wajdula J.S., Sato R. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50mg once-weekly and 25mg twice-weekly. Rheumatology (Oxford) 2007, 46(6):999-1004.
49. Bissonnette R. Etanercept for the treatment of psoriasis. Skin Ther Lett 2006, 11(1):1-4.
50. Prinz J.C., Fitzgerald O., Boggs R.I., Foehl J., Robertson D., Pedersen R., et al. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. J Eur Acad Dermatol Venereol 2011, 25(5):559-564.
51. Gao Y.J., Ji R.R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010, 126(1):56-68.
52. Cunha T.M., Verri W.A., Silva J.S., Poole S., Cunha F.Q., Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A 2005, 102(5):1755-1760.
53. Pinto L.G., Cunha T.M., Vieira S.M., Lemos H.P., Verri W.A., Cunha F.Q., et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010, 148(2):247-256.
54. Hoheisel U., Unger T., Mense S. Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 2005, 114(1-2):168-176.
55. Svensson C.I., Schäfers M., Jones T.L., Powell H., Sorkin L.S. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 2005, 379(3):209-213.
56. Boyle D.L., Jones T.L., Hammaker D., Svensson C.I., Rosengren S., Albani S., et al. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med 2006, 3(9):e338.
57. Pavao-de-Souza G.F., Zarpelon A.C., Tedeschi G.C., Mizokami S.S., Sanson J.S., Cunha T.M., et al. Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice. Pharmacol Biochem Behav 2012, 101(3):320-328.
58. Faccioli L.H., Souza G.E., Cunha F.Q., Poole S., Ferreira S.H. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions 1990, 30(3-4):344-349.
59. Meier B., Radeke H.H., Selle S., Younes M., Sies H., Resch K., et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 1989, 263(2):539-545.
60. Verri W.A., Cunha T.M., Magro D.A., Guerrero A.T., Vieira S.M., Carregaro V., et al. Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn Schmiedebergs Arch Pharmacol 2009, 379(3):271-279.
61. Wang Z.Q., Porreca F., Cuzzocrea S., Galen K., Lightfoot R., Masini E., et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004, 309(3):869-878.
62. Ndengele M.M., Cuzzocrea S., Esposito E., Mazzon E., Di Paola R., Matuschak G.M., et al. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J 2008, 22(9):3154-3164.
63. Sale D.G. Influence of exercise and training on motor unit activation. Exerc Sport Sci Rev 1987, 15:95-151.
64. Criswell D., Powers S., Dodd S., Lawler J., Edwards W., Renshler K., et al. High intensity training-induced changes in skeletal muscle antioxidant enzyme activity. Med Sci Sports Exerc 1993, 25(10):1135-1140.
65. Augusto V., Padovani C.R., Campos G.E.R. Skeletal muscle fiber types in C57BL6J mice. Braz J Morphol Sci 2004, 21(2):89-94.
66. Suarez-Roca H., Quintero L., Arcaya J.L., Maixner W., Rao S.G. Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran. Physiol Behav 2006, 88(1-2):82-87.
67. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177(3):245-255.
68. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266(5604):730-732. [21].
69. López-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22(2):191-199.
70. Hayes R.L., Bennett G.J., Newlon P.G., Mayer D.J. Behavioral and physiological studies of non-narcotic analgesia in the rat elicited by certain environmental stimuli. Brain Res 1978, 155(1):69-90.
71. Graven-Nielsen T., Arendt-Nielsen L. Induction and assessment of muscle pain, referred pain, and muscular hyperalgesia. Curr Pain Headache Rep 2003, 7(6):443-451.
72. Nieman D.C., Dumke C.L., Henson D.A., McAnulty S.R., Gross S.J., Lind R.H. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun 2005, 19(5):398-403.
73. Nieman D.C., Henson D.A., Dumke C.L., Oley K., McAnulty S.R., Davis J.M., et al. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun 2006, 20(6):578-584.
74. Tiidus P.M., Ianuzzo C.D. Effects of intensity and duration of muscular exercise on delayed soreness and serum enzyme activities. Med Sci Sports Exerc 1983, 15(6):461-465.
75. Cheung K., Hume P., Maxwell L. Delayed onset muscle soreness: treatment strategies and performance factors. Sports Med 2003, 33(2):145-164.